Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $150 | $125 | $118 |
| - Cash | $30 | $27 | $28 |
| + Debt | $7 | $4 | $4 |
| Enterprise Value | $127 | $103 | $95 |
| Revenue | $65 | $12 | $0 |
| % Growth | 442.9% | 6,601.1% | – |
| Gross Profit | $36 | $6 | $0 |
| % Margin | 55.1% | 52.6% | 100% |
| EBITDA | -$44 | -$35 | -$63 |
| % Margin | -67.7% | -288.7% | -35,418.4% |
| Net Income | -$55 | -$44 | -$65 |
| % Margin | -84.1% | -367.6% | -36,173.7% |
| EPS Diluted | -8.6 | -8.31 | -12.96 |
| % Growth | -3.5% | 35.9% | – |
| Operating Cash Flow | -$48 | -$32 | -$60 |
| Capital Expenditures | -$3 | -$0 | -$1 |
| Free Cash Flow | -$52 | -$33 | -$61 |